The International Centre for Cancer Vaccine Science (ICCVS), Team Leader of Clinical Peptidomics Group, Dr Sachin Kote, has recently represented ICCVS, University of Gdansk at the symposium of CERIC’s Future in Life Sciences – A Focus on Aging held on 13-15 October 2025 at iMol Institute, Warsaw, Poland. The symposium was organized by CERIC mainly to present the most advanced international research conducted in the Life Sciences field and to explore how CERIC, with its sophisticated analytical investigation techniques, can contribute to this research. The symposium highlights and discusses how to strengthen the bridge between the large-scale research infrastructures offered at CERIC and the biomedical research community. Dr. Sachin Kote had several interactions and discussions about potential collaboration with CERIC’s representatives and leaders, who possess a unique international infrastructure, including Austria, Croatia, the Czech Republic, Hungary, Poland, Romania, and Slovenia.

The Clinical Peptidomics group at ICCVS has mass spectrometers as state-of-the-art analytical instruments. The Clinical Peptidomics group has several innovative, EPO-patented tools, including immunopeptidomics, neo-antigen discovery, tissue extracellular peptidomics, serum peptidomics from both human and non-human biofluids, intracellular peptidomics, and routine quantitative proteomics research dedicated to enhancing health, environment, and safety. These innovative tools can be complementary implemented for several diseases to develop diagnostics and therapies for CERIC users and researchers from the EU. In addition, these novel tools generate the highest quality data, which serve as a gold mine for AI-based applications and their implementation in discoveries and therapies, said Dr. Sachin Kote.

The cooperation has been established thanks to activities in the frame of ERA SHUTTLE project – Accelerating ERA by Sharing Unique Talents for healThy Life and Environment.